What is the treatment for cellulitis (bacterial skin infection)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Cellulitis

For typical cases of cellulitis, a 5-day course of oral antibiotics active against streptococci is the recommended first-line treatment, with options including penicillin, amoxicillin, amoxicillin-clavulanate, dicloxacillin, cephalexin, or clindamycin. 1, 2

First-Line Antibiotic Selection

  • For non-purulent, uncomplicated cellulitis, oral antibiotics active against streptococci should be used, as streptococci are the predominant causative organisms 1, 2
  • Recommended first-line options include:
    • Penicillin 1, 2
    • Amoxicillin 1, 2
    • Amoxicillin-clavulanate 1, 2
    • Dicloxacillin 1, 2
    • Cephalexin (500 mg four times daily) 1, 2
    • Clindamycin (150-300 mg every 6 hours for serious infections; 300-450 mg every 6 hours for more severe infections) 1, 3

Duration of Therapy

  • A 5-day course of antimicrobial therapy is as effective as a 10-day course for uncomplicated cellulitis if clinical improvement has occurred by day 5 1, 2
  • Treatment should be extended if the infection has not improved within the initial 5-day period 4, 2
  • For β-hemolytic streptococcal infections, treatment should continue for at least 10 days 3

When to Consider MRSA Coverage

  • MRSA is an unusual cause of typical cellulitis, and routine coverage is unnecessary 1

  • Consider adding MRSA coverage only in specific situations:

    • Cellulitis associated with penetrating trauma, especially from illicit drug use 1, 2
    • Presence of purulent drainage 1, 2
    • Evidence of MRSA infection elsewhere 1, 2
    • History of previous MRSA infections 5
  • Options for MRSA coverage include:

    • Intravenous options: vancomycin, daptomycin, linezolid, or telavancin 1, 6
    • Oral options: clindamycin alone, or combination of trimethoprim-sulfamethoxazole (TMP-SMX) or doxycycline with a β-lactam 1, 2

Adjunctive Measures

  • Elevation of the affected area is important to promote gravity drainage of edema and inflammatory substances 1, 2
  • Identify and treat predisposing conditions such as:
    • Tinea pedis 2
    • Trauma to the area 2
    • Venous eczema or venous insufficiency 1, 2
  • Systemic corticosteroids (e.g., prednisone 40 mg daily for 7 days) could be considered in non-diabetic adult patients to reduce inflammation and hasten resolution 1, 2
  • Anti-inflammatory therapy may help speed resolution of cellulitis-related inflammation 7

Hospitalization Criteria

  • Consider hospitalization for patients with:
    • Severe infections with systemic inflammatory response syndrome 2
    • Altered mental status 2
    • Hemodynamic instability 2
    • Concern for deeper or necrotizing infection 2
    • Immunocompromise 2
    • Failure of outpatient treatment 2

Prevention of Recurrence

  • For patients with frequent episodes of cellulitis (annual recurrence rates of about 8%-20%), consider prophylactic antibiotics 1, 2
  • Options include oral penicillin, erythromycin, or intramuscular benzathine penicillin 4, 2
  • Address underlying conditions that predispose to recurrence, such as treating tinea pedis and managing venous insufficiency and lymphedema 2, 8

Common Pitfalls to Avoid

  • Don't automatically add MRSA coverage for typical non-purulent cellulitis without specific risk factors 1, 2
  • Don't extend treatment unnecessarily beyond 5 days if clinical improvement has occurred 1, 2
  • Don't forget to examine interdigital toe spaces in lower-extremity cellulitis, as treating fissuring or maceration may reduce recurrence 2, 8
  • Don't overlook the importance of elevating the affected area, especially in patients with venous insufficiency or lymphedema 1, 2
  • Don't rely on combination therapy with TMP-SMX plus cephalexin for pure cellulitis, as it has not been shown to be more efficacious than cephalexin alone 1, 9

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Cellulitis in Older Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Preseptal Cellulitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cellulitis.

Infectious disease clinics of North America, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.